NCT05332223Completed
The Epidemiology of Sleep Disordered Breathing in Patients With Congestive Heart Failure
The Epidemiological Characteristics of Sleep Disordered Breathing in Patients With Reduced or Preserved Ejection Fraction Congestive Heart Failure
Source: ClinicalTrials.gov · Last updated 15 Feb 2024
Brief summary (registry, in English)
This research will be one of the first hospital-based studies to comprehensively evaluate the epidemiological characteristics of sleep disordered breathing (SDB) in patients with Congestive Heart Failure (CHF). This prospective, observational cohort, single center study will include all consecutive CHF outpatients from the specialized heart failure clinic in Medical Department, Hospital Taiping, Malaysia irrespective of preserved or depressed Left Ventricular Ejection Fraction (LVEF). All participants will be subjected to an attended in-laboratory polysomnogram (PSG). It is anticipated the frequency and types of SDB to be variable compared to western data as this subject remains understudied in the South East Asian population. This research utilizes PSG rather than Portable Sleep Testing (PST) as seen in preceding studies for the diagnosis of SDB to prevent underdiagnosing SDBs and clearly distinguishing Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 116 (actual)
- First submitted
- 4 Apr 2022
- Start date
- 15 Apr 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Ministry of Health, Malaysia
- Diseases
- Heart failure
- NCT number
- NCT05332223
What you commit to
- Study type: Observational
- Participants enrolled: 116
- From 15 Apr 2022 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who had been diagnosed with SDB or is treated with any form of Positive Airway Pressure (PAP) therapy prior to this will be excluded from this study.
Who the study is looking for
- All patients with CHF regardless of LVEF Participants need to be older than 18 years old and is able to understand study information and give informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Taiping Coordinator of this site? Confirm its status | Taiping | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.